Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores - Takeaways - MDSpire

Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores

  • By

  • Sami-Ramzi Leyh-Bannurah

  • Svitlana Boiko

  • Dirk Beyersdorff

  • Fabian Falkenbach

  • Jonas Ekrutt

  • Tobias Maurer

  • Markus Graefen

  • Mykyta Kachanov

  • Lars Budäus

  • May 2, 2022

  • 0 min

Share

  • 1

    Systematic transrectal ultrasound-guided biopsy is commonly used for prostate cancer diagnosis, but targeted biopsy shows superior accuracy.

  • 2

    Pan-segmental mid-apical lesions are more common than isolated apex lesions, necessitating tailored biopsy strategies.

  • 3

    Extreme apical biopsy cores may not significantly enhance detection of clinically significant prostate cancer in mid-apical lesions.

  • 4

    The study analyzed 420 patients with mid-apical lesions, revealing a 44% detection rate of clinically significant prostate cancer.

  • 5

    Optimizing targeted biopsy strategies could reduce morbidity while maintaining diagnostic efficacy for prostate cancer.

Original Source(s)

Related Content